[ad_1]
New treatment cures liver and Alzheimer's infections
Scientists from the University of California have discovered that a treatment designed for liver infections was treating other things, which is unexpected: a drug approved by the FDA (Food and Drug Administration).
The drug was originally prescribed by the Food and Drug Administration for the treatment of hepatitis D, a hepatitis virus that passes through body fluids but has become New treatment cures liver and Alzheimer's infections Together
In the new study, scientists were able to carry out genetic engineering of the mice with a protein believed to cause Alzheimer's disease.
"Although Tao-related diseases, including Alzheimer's disease and chronic encephalopathy, are serious public health problems, there is currently no cure for altering the disease." disease, "said D Hernandez of the University of California.
The researchers then investigated the potential of this lonafarnib compound in mice, which has been extensively studied as a treatment for hepatitis D and progeria, a rare aging disorder.
This study suggests that treatment with Ionafarnib may be effective only in the early stages of the disease, thus reinforcing the importance of research for the early detection of diseases such as Alzheimer's disease.
Read more: "Ribavirin", the latest drugs against the chronic hepatitis virus
This article is a new treatment against liver and Alzheimer's infections, derived from the citizen's website, which in no way reflects the site's policy or the person's point of view, and which bears the responsibility for the News or the authenticity of the source of the information of origin.
[ad_2]
Source link
